In patients with polycystic ovary syndrome, increased ET-1 levels are thought to contribute to the development of insulin resistance [151], which could be via the inhibition of glucose uptake and insulin-stimulated Akt phosphorylation [152]. The gene discussed is INS; the disease is Insulin resistance.